Filing Details
- Accession Number:
- 0000899243-20-010122
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-04-03 16:13:14
- Reporting Period:
- 2020-04-01
- Accepted Time:
- 2020-04-03 16:13:14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1743881 | Bridgebio Pharma Inc. | BBIO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1779990 | Thomas Michael Henderson | C/O Bridgebio Pharma, Inc. 421 Kipling Street Palo Alto CA 94301 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-04-01 | 44 | $25.40 | 170,268 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-01 | 1,441 | $26.51 | 168,827 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-04-01 | 1,100 | $27.56 | 167,727 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on November 29, 2019.
- Represents the weighted average sale price of the shares sold from $26.15 to $27.07 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 2 and 3.
- Represents the weighted average sale price of the shares sold from $27.18 to $28.11 per share.
Billionaire Hedge Funds
